Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) Operating Margin (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Operating Margin for 6 consecutive years, with 40.64% as the latest value for Q4 2025.

  • On a quarterly basis, Operating Margin fell 1175.0% to 40.64% in Q4 2025 year-over-year; TTM through Dec 2025 was 33.71%, a 932.0% increase, with the full-year FY2025 number at 33.71%, up 932.0% from a year prior.
  • Operating Margin was 40.64% for Q4 2025 at PROCEPT BioRobotics, down from 27.83% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 27.83% in Q3 2025 to a low of 166.04% in Q4 2021.
  • A 5-year average of 85.45% and a median of 75.18% in 2023 define the central range for Operating Margin.
  • Biggest YoY gain for Operating Margin was 37339bps in 2021; the steepest drop was -91177bps in 2021.
  • PROCEPT BioRobotics' Operating Margin stood at 166.04% in 2021, then skyrocketed by 37bps to 105.31% in 2022, then soared by 36bps to 67.82% in 2023, then skyrocketed by 57bps to 28.89% in 2024, then plummeted by -41bps to 40.64% in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Operating Margin are 40.64% (Q4 2025), 27.83% (Q3 2025), and 28.02% (Q2 2025).